Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israele, Tel Aviv-Giaffa
Pelles Sharon
23 anni di esperienza
Clinica certificata da :
| Israele | Turchia | Austria | |
| Resezione del cancro del colon | da $22,500 | da $14,400 | da $20,000 |
| Resezione rettale | da $24,500 | da $10,250 | da $21,000 |
| Colectomia (resezione del colon) | da $20,500 | da $6,912 | da $22,000 |
| Mesorettomectomia totale robotica | - | da $14,500 | - |
| Mesorettomectomia laparoscopica | - | da $9,500 | - |
Bookimed non aggiunge costi extra ai prezzi di Resezione del cancro del colon. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica per la tua Resezione del cancro del colon al tuo arrivo.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali in Resezione del cancro del colon e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di Resezione del cancro del colon.
Giorno 1 - Arrivo
Giorno 2 - Pre-operatorio
Giorno 3 - Giorno dell'intervento
Giorno 4 - Post-operatorio
Giorni da 5 a 7 - Degenza ospedaliera
Settimane da 1 a 3 - Riabilitazione a casa
Settimana 4 - Ritorno al lavoro
Settimana 6 - Ritorno all'attività sportiva
Si prega di notare che i tempi di recupero e l'esperienza di ogni paziente possono variare in base alle circostanze individuali e alle specificità dell'intervento eseguito.
Esperto di spicco in oncologia dei sarcomi e delle ossa presso il Sourasky Medical Center con oltre 25 anni di esperienza specializzata.
La Dott.ssa Pelles Sharon è specializzata nel trattamento del cancro del colon presso il Sourasky Medical Center, combinando l'esperienza chirurgica con tecniche avanzate come HIPEC e l'immunoterapia.
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.
Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.
MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.
Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.